Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
A new treatment option for CMV infections through targeting of its receptor
| Reference number | 2014-01156 |
| Coordinator | Karolinska Institutet - Institutionen för medicin, Solna |
| Funding from Vinnova | SEK 2 000 000 |
| Project duration | March 2014 - March 2016 |
| Status | Completed |
